Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Upper and/or lower gastrointestinal adverse events with glucagon-like peptide-1 receptor agonists: incidence and consequences
Standard delivery is subcutaneous injection
Autonomous weapons and disruptive technologies could be regulated through international treaties and oversight to mitigate the risks of catastrophic conflicts
Youre comfortable with an async consultation model
Reduced incretin effect in type 2 [non-insulin-dependent] diabetes
Retatrutide 10mg CAS 2381089-83-2 GLP-1 & Metabolic $23/vial under 1,000 vials $15/vial 1,000+ Sold in boxes of 10 vials 100-vial order minimum (mix & match) 1,000+ unlocks the lower price Retatrutide 30mg CAS 2381089-83-2 GLP-1 & Metabolic $40/vial under 1,000 vials $28/vial 1,000+ Sold in boxes of 10 vials 100-vial order minimum (mix & match) 1,000+ unlocks the lower price Retatrutide 60mg CAS 2381089-83-2 GLP-1 & Metabolic $65/vial under 1,000 vials $51/vial 1,000+ Sold in boxes of 10 vials 100-vial order minimum (mix & match) 1,000+ unlocks the lower price Overview Retatrutide is a synthetic investigational peptide developed as a multi-pathway agonist, representing the next generation of metabolic research compounds
